PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 152 filers reported holding PDL BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $18,629,000 | +7.3% | 5,914,315 | -0.9% | 0.00% | 0.0% |
| Q2 2020 | $17,365,000 | +9.4% | 5,967,537 | +6.0% | 0.00% | 0.0% |
| Q1 2020 | $15,871,000 | -11.5% | 5,627,989 | +1.9% | 0.00% | 0.0% |
| Q4 2019 | $17,925,000 | +33.0% | 5,523,952 | -11.5% | 0.00% | – |
| Q3 2019 | $13,480,000 | -54.0% | 6,241,144 | -33.1% | 0.00% | -100.0% |
| Q2 2019 | $29,287,000 | -25.9% | 9,326,891 | -12.3% | 0.00% | -50.0% |
| Q1 2019 | $39,549,000 | +35.3% | 10,631,361 | +5.5% | 0.00% | +100.0% |
| Q4 2018 | $29,230,000 | +6.2% | 10,079,388 | -3.7% | 0.00% | 0.0% |
| Q3 2018 | $27,530,000 | -10.7% | 10,467,525 | -20.6% | 0.00% | 0.0% |
| Q2 2018 | $30,839,000 | -16.3% | 13,178,960 | +5.2% | 0.00% | -50.0% |
| Q1 2018 | $36,840,000 | +3.8% | 12,530,868 | -3.3% | 0.00% | 0.0% |
| Q4 2017 | $35,497,000 | -16.0% | 12,955,201 | +3.9% | 0.00% | 0.0% |
| Q3 2017 | $42,253,000 | +32.9% | 12,463,833 | -3.2% | 0.00% | 0.0% |
| Q2 2017 | $31,790,000 | -1.2% | 12,870,461 | -9.2% | 0.00% | 0.0% |
| Q1 2017 | $32,188,000 | +13.7% | 14,180,118 | +6.2% | 0.00% | 0.0% |
| Q4 2016 | $28,307,000 | -37.5% | 13,352,288 | -1.2% | 0.00% | -33.3% |
| Q3 2016 | $45,281,000 | +26.5% | 13,516,730 | +18.6% | 0.00% | +50.0% |
| Q2 2016 | $35,794,000 | -0.8% | 11,399,443 | +5.2% | 0.00% | 0.0% |
| Q1 2016 | $36,090,000 | -9.0% | 10,838,038 | -3.2% | 0.00% | -33.3% |
| Q4 2015 | $39,642,000 | -29.1% | 11,198,268 | +0.7% | 0.00% | +50.0% |
| Q3 2015 | $55,915,000 | -22.6% | 11,116,256 | -1.0% | 0.00% | -60.0% |
| Q2 2015 | $72,223,000 | -10.9% | 11,232,238 | -2.5% | 0.01% | 0.0% |
| Q1 2015 | $81,053,000 | -6.6% | 11,521,374 | +2.4% | 0.01% | -16.7% |
| Q4 2014 | $86,771,000 | +12.4% | 11,254,413 | +8.9% | 0.01% | 0.0% |
| Q3 2014 | $77,171,000 | -21.6% | 10,330,726 | +1.6% | 0.01% | -25.0% |
| Q2 2014 | $98,443,000 | +19.0% | 10,169,706 | +2.1% | 0.01% | +14.3% |
| Q1 2014 | $82,747,000 | +12.2% | 9,957,477 | +14.0% | 0.01% | +16.7% |
| Q4 2013 | $73,751,000 | +6.9% | 8,738,301 | +1.0% | 0.01% | -14.3% |
| Q3 2013 | $68,964,000 | +10.7% | 8,652,986 | +7.2% | 0.01% | 0.0% |
| Q2 2013 | $62,298,000 | – | 8,069,634 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |